Related Experiment Video

Updated: Apr 17, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
07:01

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

2.0K

Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI

Ana Carolina P Souza1, Peter S T Yuen1, Robert A Star1

  • 1Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Kidney International
|February 19, 2015
PubMed

Insights

Microparticles (MPs) are cell fragments involved in sepsis pathogenesis. These particles contribute to endothelial dysfunction and organ damage, offering potential therapeutic targets for this severe condition.

Area of Science:

  • Biomedical Science
  • Pathophysiology
  • Vascular Biology

Background:

  • Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • Effective prevention and therapeutics for sepsis remain elusive.
  • The microvasculature is a critical target for understanding sepsis progression.

Purpose of the Study:

  • To highlight the role of microparticles (MPs) in sepsis-induced microvascular injury.
  • To discuss the mechanisms by which MPs contribute to sepsis pathogenesis.
  • To explore MPs as potential diagnostic markers and therapeutic targets in sepsis.

Main Methods:

  • Review of current literature on microparticle generation and function in sepsis.
  • Analysis of the molecular constituents of MPs, including phosphatidylserine and tissue factor.
  • Discussion of MP-mediated effects on endothelial cells and organ systems.

Main Results:

  • Microparticles are released from endothelial and circulating cells following sepsis.
  • MPs promote coagulation, inflammation, and angiogenesis.
  • MPs contribute to endothelial dysfunction, immunosuppression, and multiorgan dysfunction, including sepsis-associated acute kidney injury (sepsis-AKI).

Conclusions:

  • Microparticles are emerging as key mediators in sepsis pathogenesis, not merely cellular byproducts.
  • Understanding MP function provides insights into sepsis pathophysiology.
  • MPs represent a promising new class of biomarkers and therapeutic targets for sepsis.

More Related Videos

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

701
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration12:27

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Published on: June 7, 2014

51.7K

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.3K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
502